GlobeNewsWire
16 Nov 2026, 10:47 UTC · 14h ago
Investor Notice: Alignment Healthcare (NASDAQ:ALHC) being Investigated for Securities Fraud after Inflated EBITDA Allegations Cause 16% Stock Drop – Contact BFA Law
Impact · against what's priced in
The stock is under severe pressure following allegations of inflated EBITDA, which suggests current valuation multiples are based on artificial earnings. The initiation of a securities fraud investigation by a law firm adds legal risk to the existing financial uncertainty.
- ALHC−0.70
No priced-in read yet





